Working To Reach Everyone, Everywhere
Our commitment to equitable access
Pfizer is firmly committed to equitable and affordable access to the Pfizer-BioNTech COVID-19 vaccine to help bring an end to the pandemic for everyone, everywhere.
We are extremely proud of the fact that, to-date, 140 countries around the world have received doses of the Pfizer-BioNTech vaccine, and we are working to increase that reach as quickly as possible.
Every day, we are working tirelessly with governments and our global health partners to ensure doses reach the arms of even more people.
Pfizer and BioNTech will produce 3 billion doses in 2021 and 4 billion doses in 2022
We have pledged:
2 billion doses
to low- and middle-income countries through 2022 - at least one billion each year - in order to reach lower income countries and the 2/3rds of the world’s poor living in middle income countries.
As of October 10, 2021, Pfizer has delivered:
1.8 billion doses to 146 countries
557 million + doses
to low and middle income countries as part of this pledge, and we are hard at work, along with our partners, planning for substantial doses deliveries that will take place through the rest of 2021.
In order to reach this commitment, we rely on multiple pathways to enable the fastest and most efficient ways to get vaccines to countries of all economic levels around the world and to leverage the resources and expertise of partners who can offer support for logistics, financing and advocacy where they may be needed. This includes: